Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/2010
06/17/2010US20100152189 Novel polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3[4-(3-oxo-4-morpholinyl(-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
06/17/2010US20100152182 2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100152131 Method for producing purified hematinic iron-saccharadic complex and product produced
06/17/2010US20100152106 Agent for therapy and/or improvement of disseminated intravascular coagulation
06/17/2010US20100152097 Polymer-based sustained release device
06/17/2010US20100151049 Materials and methods for preparation of alkaline earth ferrates from alkaline earth oxides, peroxides, and nitrates
06/17/2010US20100151019 SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS WITH POOR AQUEOUS SOLUBILITY AT LOW pH AND METHODS OF USE THEREOF
06/17/2010US20100150913 Organic compounds
06/17/2010US20100150899 Pyrazolinone scavengers of free radical
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010US20100150883 Stem cells treated by in vitro fucosylation and methods of use
06/17/2010US20100150882 Hucbc treatment of amyloid associated disease
06/17/2010CA2746422A1 Kinase inhibitor compounds
06/17/2010CA2745969A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/16/2010EP2196533A1 Novel microorganism having gastric juice promoting action and composition secreted by the same
06/16/2010EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine
06/16/2010CN1921847B Amino alcohol compound
06/16/2010CN1886141B T-type calcium channel inhibitor
06/16/2010CN1518558B Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament
06/16/2010CN1517126B Drug compastion with thrombolysis, anti-inflammatory and cell protective function
06/16/2010CN1393446B 稠合吡唑化合物 Fused pyrazole compounds
06/16/2010CN101743244A Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
06/16/2010CN101743010A Stable fat emulsion containing prostaglandin e1
06/16/2010CN101743001A Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
06/16/2010CN101736406A Method for discovering active components of traditional Chinese medicine by metabolic forecast and virtual sieving
06/16/2010CN101735924A Womb warming youth wine
06/16/2010CN101735923A Health care wine for eliminating sub-health
06/16/2010CN101735336A Oligomeric fucosylated glycosaminoglycan and preparation method thereof
06/16/2010CN101735307A Platelet envelope glycoprotein oligopeptide or trim/derivate thereof and application thereof
06/16/2010CN101735240A New preparation method for hexahydrothieno [3, 2-c] pyridine derivatives
06/16/2010CN101735168A P-sulfamyl benzylidene cyclic ketone compounds, preparation method and application thereof
06/16/2010CN101735131A New salts
06/16/2010CN101732702A Sturgeon bacterial sepsis syndrome holophagae inactivating vaccine and preparation method thereof
06/16/2010CN101732690A Formula for treating phlebothrombosis and preparation method thereof
06/16/2010CN101732678A Chinese medicinal powder for stopping bleeding, diminishing inflammation and promoting regeneration of mucosa
06/16/2010CN101732625A Treating formula of thrombophlebitis of chest and abdominal wall and making method thereof
06/16/2010CN101732566A Traditional Chinese medicine compound preparation for tonifying liver and kidney and strengthening bones and muscles
06/16/2010CN101732559A Chinese medicament for treating diabetes insipidus
06/16/2010CN101732534A Traditional Chinese medicine for tonifying kidney, producing sperm, supplementing qi and nourishing blood
06/16/2010CN101732497A Chinese medicinal preparation for treating skin injury and preparation method thereof
06/16/2010CN101732486A Health-preserving wine
06/16/2010CN101732484A Capsule for restoring vital energy and producing blood
06/16/2010CN101732391A Method for enriching and purifying cardiac glycoside of wormseed mustard herb
06/16/2010CN101732384A Extract for treating nephritis, and preparation method and use thereof
06/16/2010CN101732374A Health-care medicinal granules for preventing anaemia and preparation method thereof
06/16/2010CN101732328A Medicinal composition and injection for treating swine eperythrozoonosis, and preparation methods thereof
06/16/2010CN101732299A Medicinal composition containing ferulic acid and matrine compounds and application thereof
06/16/2010CN101732287A Injection of mannite and glycerol and preparation method thereof
06/16/2010CN101732279A Aspirin enteric coated tablet with low content of free salicylic acid and preparation process thereof
06/16/2010CN101732278A Coating technology of chlorophyll copper sodium tablet film
06/16/2010CN101439089B Medicament containing oxymatrine
06/16/2010CN101439088B Medicament for promoting leucocyte hyperplasia
06/16/2010CN101249221B Chinese medicine for curing cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombus
06/16/2010CN101204371B Vitamin C injection and preparation method thereof
06/16/2010CN101185657B Production process and device for donkey-hide gelatin plasma substitutes
06/16/2010CN101116684B Mongolian medicine for treating cerebrovascular disease
06/16/2010CN101053354B Producing technology for natural pine needle tea
06/16/2010CN101002625B Beverage for relieving summer heat, and its preparing process
06/15/2010US7737161 such as 5-amino-N-(5-chloropyridin-2-yl)-3-{[(trans-4-pyrrolidin-1-ylcyclohexyl)carbonyl]amino}furo[3,2-b]pyridine-2-carboxamide, used as activated blood coagulation factor X inhibitors
06/15/2010US7737136 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives
06/15/2010US7736678 Method of enhancing blood antioxidant activity ingesting a compound in the form of at least one form selected from amongst juice, powder, granule, tablet and capsule, which contains an effective amount of at least one vegetable selected from the group consisting of broccoli, spinach, parsley, komatsuna (Brassicad rapa L.) and japanese radish leaves, and at least one vegetable selected from amongst lettuce, cabbage and celery
06/15/2010US7736676 Synergistic composition for the treatment of diabetes mellitus
06/15/2010CA2529686C 2-acylaminothiazole derivative or salt thereof
06/15/2010CA2493391C Novel thiophene glycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
06/15/2010CA2430518C Guanidine and amidine derivatives as factor xa inhibitors
06/15/2010CA2366833C Hemoglobin-antioxidant conjugates
06/10/2010WO2010065717A1 Morpholinone compounds as factor ixa inhibitors
06/10/2010WO2010065479A2 Compositions and methods using alpha beta-crystallin in protecting the myocardium from ischemia/reperfusion injury
06/10/2010WO2010064324A1 Intravascular indwelling catheter lock solution containing acetic acid and container containing the same
06/10/2010WO2010063823A1 Method for producing platelets
06/10/2010US20100144791 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
06/10/2010US20100144711 Pharmaceutical composition for oral administration
06/10/2010US20100144698 Substituted azetidinones
06/10/2010US20100144675 Regulation of sGC Function by Corrin Derivatives
06/10/2010US20100144661 Sodium channel blockers
06/10/2010US20100144632 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
06/10/2010US20100144624 Process for the preparation of compositions of at1 receptor antagonist and angiotensin-(1-7)
06/10/2010US20100144622 Methods for production of recombinant plasminogen and plasmin polypeptides
06/10/2010US20100144620 Complementation of factor xi deficeincy by factor v mutants
06/10/2010US20100144596 An Apo-Ferredoxin Preparation, A Process For Producing Same And Uses Thereof
06/10/2010US20100144595 Lyophilization of Hemoglobin Solutions
06/10/2010US20100143492 Coagulation and fibrinolytic cascades modulator
06/10/2010US20100143474 B-carboline for the treatment of neurodegenerative diseases
06/10/2010US20100143468 Tranexamic Acid Formulations
06/10/2010US20100143420 Multi-phasic pharmaceutical formulations of poorly water-soluble drugs for reduced fed/fasted variability and improved oral bioavailability
06/10/2010US20100143379 Mif agonists and antagonist and therapeutic uses thereof
06/10/2010US20100143326 SUBCUTANEOUS ADMINISTRATION OF COAGULATION FACTOR VIIa-RELATED POLYPEPTIDES
06/10/2010US20100143314 In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy
06/10/2010US20100143294 Antagonists of il-6 to prevent or treat thrombosis
06/10/2010DE102008060967A1 Substituierte Phenylsulfonyltriazolone und ihre Verwendung Substituted Phenylsulfonyltriazolone and their use
06/10/2010CA2745268A1 Method for producing platelets
06/10/2010CA2745121A1 Morpholinone compounds as factor ixa inhibitors
06/10/2010CA2745101A1 Intravascular indwelling catheter lock solution containing weak acid and container containing the same
06/09/2010EP2194130A1 Cytokine ZCYTO18
06/09/2010EP2194057A1 Stable crystalline salts of 5-methyltetrahydrofolic acid
06/09/2010EP2194046A1 Triazolone derivative
06/09/2010EP2193809A1 Albumin-free factor VIII formulations
06/09/2010EP1497273B1 Hydroxamic acid derivatives
06/09/2010EP1292308B1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
1 ... 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 ... 671